Medtech Groups To Blitz Congress Before Expected House Device Tax Vote

After Minnesota Congressman Erik Paulsen seemed to confirm plans for a floor vote on the medical device excise tax repeal before August, medical device lobby groups say they are rallying to get the deal done before it gets pushed off the agenda by the upcoming US Supreme Court nomination process.

US Capitol building, Washington DC (f11photo/Shutterstock.com)

Medical device lobby groups plan to start a new campaign blitz after Congress returns from the Fourth of July recess to pass a standalone medical device tax repeal bill in the US House. With Supreme Court Justice Anthony Kennedy's retirement imminent, they want to make sure the bill doesn't get knocked off the agenda by what's expected to be a heated court nomination battle in the Senate, according to AdvaMed spokesman Greg Crist.

AdvaMed says it will be flying CEOs from around the country in to Washington, DC, in the next two days to knock on doors on Capitol Hill and ask House lawmakers to repeal the 2.3% medical device excise tax. As in past campaigns, Crist says the group is teaming up with other device lobby groups, including the Medical Device Manufacturers Association (MDMA), to achieve their common goal

More from Legislation

More from Policy & Regulation

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By 

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.

Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

 

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.

Global Medtech Guidance Tracker: April 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 25 documents have been posted on the tracker since its last update.